Exabis Library
Welcome to the e-CCO Library!
P405 Comparison of long-term outcomes of infliximab vs. adalimumab in 1488 biologic-naive Korean patients with Crohn’s disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P405: 5-ASA prescription trends over time in inflammatory bowel disease 1996 to 2015–A UK population-based study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P405: Development and validation of a rapid immunoassay for monitoring of ustekinumab concentrations in Inflammatory Bowel Disease patients
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P405: Infliximab trough level measured during treatment induction may be predictive of the loss of response to Infliximab during treatment maintenance in inflammatory bowel disease patients: a longitudinal observational retrospective study
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P405: Long-term safety of 3 years of ozanimod in moderately to severely active ulcerative colitis: an interim analysis of the True North open-label extension
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P405: Primary non-response and loss-of-response to first-line biological therapies are more common in patients with Ulcerative Colitis than Crohn’s Disease – preliminary results from the Danish IBD Biobank Project
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P405: Sustainability of biologic therapies is less in UC than CD patients independent of prior biologic experience
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P405: Toxicity of thiopurines in patients with inflammatory bowel disease: inventory and predictive factors
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P406 Adherence, acceptability and serum trough concentration of adalimumab autoinjector in quiescent patients with inflammatory bowel diseases
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P406: A retrospective analysis of the efficacy of vedolizumab on extra-intestinal manifestations in patients with inflammatory bowel disease across five European countries
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P406: AlphaE+ cells have increased expression of inflammatory markers and are correlated in the ileum and colon
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P406: Clinical correlations of infliximab trough levels and antibodies to infliximab in Korean patients with Crohn's disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P406: Disease clearance in patients with ulcerative colitis treated with aminosalicylates
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P406: General health status in patients with moderate to severe ulcerative colitis receiving ustekinumab: results from the Phase 3 UNIFI induction and maintenance studies
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P406: Malnutrition during hospitalisation for acute severe IBD is associated with increased risk of relapse
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P406: Observational study of the effectiveness of vedolizumab on treatment outcomes and health-related quality of life in biologic-naïve patients with Inflammatory Bowel Diseases in Greece – the TROVE study - Interim Analysis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P407 Is the rapid infliximab infusion a safe and cost-saving strategy in paediatric inflammatory bowel disease?
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P407: A Phase IB/IIA study of remestemcel-L, an allogeneic bone marrow derived mesenchymal stem cell product, for the treatment of medically refractory ulcerative colitis: An interim analysis
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P407: Clinical manifestations of thiopurine S-methyltransferase variants in Korean paediatric patients with inflammatory bowel disease
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P407: Efficacy and safety of etrasimod in subjects with moderately to severely active isolated proctitis: a subgroup analysis of the phase 3 ELEVATE UC 52 and ELEVATE UC 12 trials
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM